Commented Articles

PanNASH covers commented articles ans publications to acquire sufficient information, understanding, and skills to cope with NASH/NAFLD healthcare demands.

Identifying patients with high-risk NASH: three ultrasound markers

Identifying patients with high-risk-NASH who are candidates for pharmacologic therapy remains a challenge. K. Sugimoto et al. (Tokyo Medical University, Japan) aimed to develop a score to identify patients with a NAFLD activity score of 4 or greater and clinically significant fibrosis...

Read MoreIdentifying patients with high-risk NASH: three ultrasound markers

Genetic and epigenetic factors determining NAFLD risk

Predicting the individual risk of NAFLD and determining the probability of disease progression is the basis for further developing prevention and treatment strategies. This requires knowledge of the genetic and epigenetic modifiers of NAFLD for genotype-guided risk stratification...

Read MoreGenetic and epigenetic factors determining NAFLD risk

A link between hyperuricemia and NAFLD

An elevated level of plasma uric acid has been widely recognised as a risk factor for NAFLD, where oxidative stress and inflammation play an important role in the pathophysiology of the disease. Although the complete molecular mechanisms involved remain unknown, while under physiological conditions uric acid presents antioxidant properties...
Read MoreA link between hyperuricemia and NAFLD

Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation

Xanthine oxidoreductase is an enzyme that catalyses hypoxanthine to xanthine and xanthine to uric acid, respectively. However, the underlying mechanisms of increased plasma xanthine oxidoreductase and its pathological roles in systemic diseases, such as atherosclerosis, are not fully understood...

Read MoreIncreased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation

Serum uric acid level and NAFLD in T2DM patients

This study aimed to investigate the association between serum uric acid level and NAFLD in 583 patients with type 2 diabetes (T2DM) hospitalised in the Department of Hepatology, Yantai Qishan Hospital (China). In this study, multivariate regression analyses demonstrated that after adjusting for confounding factors...

Read MoreSerum uric acid level and NAFLD in T2DM patients

Sugar and fat increase the risk of advanced liver disease

In this editorial, P. Manka Essen University Hospital, Germany) and W. K. Syn (Medical University of South Carolina, USA) comment a study by Benhammou and colleagues, who evaluated the effects of NAFLD risk factors including obesity and diabetes on the long-term outcomes of patients with HCV treated with direct-acting antivirals...

Read MoreSugar and fat increase the risk of advanced liver disease

Phytomedicines in experimental models of NAFLD

This systematic review aims to investigate the potential multi-targeting effects of plant-derived extracts in experimental models of NAFLD. The authors, A. Ore et al., (Ajayi Crowther University, Oyo, and Federal University of Agriculture, Abeokuta, Nigeria) identified 9 articles fulfilling their inclusion criteria...

Read MorePhytomedicines in experimental models of NAFLD